TY - JOUR
T1 - FACT is a sensor of DNA torsional stress in eukaryotic cells
AU - Safina, Alfiya
AU - Cheney, Peter
AU - Pal, Mahadeb
AU - Brodsky, Leonid
AU - Ivanov, Alexander
AU - Kirsanov, Kirill
AU - Lesovaya, Ekaterina
AU - Naberezhnov, Denis
AU - Nesher, Elimelech
AU - Koman, Igor
AU - Wang, Dan
AU - Wang, Jianming
AU - Yakubovskaya, Marianna
AU - Winkler, Duane
AU - Gurova, Katerina
N1 - Publisher Copyright:
© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.
PY - 2017/2/28
Y1 - 2017/2/28
N2 - Transitions of B-DNA to alternative DNA structures (ADS) can be triggered by negative torsional strain, which occurs during replication and transcription, and may lead to genomic instability. However, how ADS are recognized in cells is unclear. We found that the binding of candidate anticancer drug, curaxin, to cellular DNA results in uncoiling of nucleosomal DNA, accumulation of negative supercoiling and conversion of multiple regions of genomic DNA into left-handed Z-form. Histone chaperone FACT binds rapidly to the same regions via the SSRP1 subunit in curaxin-treated cells. In vitro binding of purified SSRP1 or its isolated CID domain to a methylated DNA fragment containing alternating purine/pyrimidines, which is prone to Z-DNA transition, is much stronger than to other types of DNA. We propose that FACT can recognize and bind Z-DNA or DNA in transition from a B to Z form. Binding of FACT to these genomic regions triggers a p53 response. Furthermore, FACT has been shown to bind to other types of ADS through a different structural domain, which also leads to p53 activation. Thus, we propose that FACT acts as a sensor of ADS formation in cells. Recognition of ADS by FACT followed by a p53 response may explain the role of FACT in DNA damage prevention.
AB - Transitions of B-DNA to alternative DNA structures (ADS) can be triggered by negative torsional strain, which occurs during replication and transcription, and may lead to genomic instability. However, how ADS are recognized in cells is unclear. We found that the binding of candidate anticancer drug, curaxin, to cellular DNA results in uncoiling of nucleosomal DNA, accumulation of negative supercoiling and conversion of multiple regions of genomic DNA into left-handed Z-form. Histone chaperone FACT binds rapidly to the same regions via the SSRP1 subunit in curaxin-treated cells. In vitro binding of purified SSRP1 or its isolated CID domain to a methylated DNA fragment containing alternating purine/pyrimidines, which is prone to Z-DNA transition, is much stronger than to other types of DNA. We propose that FACT can recognize and bind Z-DNA or DNA in transition from a B to Z form. Binding of FACT to these genomic regions triggers a p53 response. Furthermore, FACT has been shown to bind to other types of ADS through a different structural domain, which also leads to p53 activation. Thus, we propose that FACT acts as a sensor of ADS formation in cells. Recognition of ADS by FACT followed by a p53 response may explain the role of FACT in DNA damage prevention.
UR - http://www.scopus.com/inward/record.url?scp=85018384362&partnerID=8YFLogxK
U2 - 10.1093/nar/gkw1366
DO - 10.1093/nar/gkw1366
M3 - Article
C2 - 28082391
AN - SCOPUS:85018384362
SN - 0305-1048
VL - 45
SP - 1925
EP - 1945
JO - Nucleic Acids Research
JF - Nucleic Acids Research
IS - 4
ER -